OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Eugenia Trushina

6 Projects | 1 Researchers | $1,966,757 Invested

2020

Mayo Clinic Rochester

Eugenia Trushina, PhD

Development of Small Molecules Modulators of Mitochondrial Function

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2017

Mayo Clinic Rochester

Eugenia Trushina, PhD

Small Molecule Inhibitors of Mitochondrial Complex I for Treatment of Alzheimer's Disease

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2015

Mayo Clinic Rochester

Eugenia Trushina, PhD

Lead Discovery of Novel Small Molecule Compounds Effective in Modulation of Mitochondrial Function

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2013

Mayo Clinic Rochester

Eugenia Trushina, PhD

Lead Discovery of Novel Small Molecule Compounds Effective in Restoration of Mitochondrial Function-Year 2

  • Funding Amount: $140,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2012

Mayo Clinic Rochester

Eugenia Trushina, PhD

Mechanism of restoration of mitochondrial function by tricyclic pyrone compounds

  • Funding Amount: $181,757
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2009

Mayo Clinic Rochester

Eugenia Trushina, PhD

Tricyclic Pyrone compounds and axonal trafficking dysfunction in AD

  • Funding Amount: $145,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed